[8-K] Apyx Medical Corporation Reports Material Event
Apyx Medical Corporation reported the outcomes of proposals submitted at its annual meeting. Stockholders elected five directors to serve on the board until the 2026 annual meeting, with each nominee receiving between 18.88 million and 19.11 million votes in favor and 6.77 million broker non-votes recorded in those tallies. Shareholders ratified RSM US LLP as the company’s independent registered public accounting firm by a vote of 25,930,634 in favor. A non-binding advisory vote on executive compensation passed with 18,963,101 votes for. A separate advisory vote on frequency favored a one-year option (9,205,086 votes). Stockholders also approved an amendment to delete the text of Article EIGHTH, with 19,047,016 votes for.
Apyx Medical Corporation ha reso noti i risultati delle proposte sottoposte all'assemblea annuale. Gli azionisti hanno eletto cinque amministratori del consiglio per il mandato fino all'assemblea del 2026; ciascun candidato ha ottenuto tra 18.88 million e 19.11 million voti favorevoli, con 6.77 million di broker non-votes registrati in quei conteggi. I soci hanno ratificato RSM US LLP come società di revisione contabile indipendente con 25,930,634 voti a favore. Un voto consultivo non vincolante sulla retribuzione dei dirigenti è passato con 18,963,101 voti favorevoli. Una separata votazione consultiva sulla frequenza ha privilegiato l'opzione di one-year (9,205,086 voti). Gli azionisti hanno inoltre approvato una modifica per eliminare il testo dell'Article EIGHTH, con 19,047,016 voti a favore.
Apyx Medical Corporation informó los resultados de las propuestas sometidas a la junta anual. Los accionistas eligieron a cinco directores para que formen parte del consejo hasta la junta de 2026; cada nominado recibió entre 18.88 million y 19.11 million votos a favor, y se registraron 6.77 million de broker non-votes en esos recuentos. Los accionistas ratificaron a RSM US LLP como la firma independiente de auditoría con 25,930,634 votos a favor. Una votación consultiva no vinculante sobre la compensación ejecutiva fue aprobada con 18,963,101 votos a favor. Una votación consultiva separada sobre la frecuencia favoreció la opción de one-year (9,205,086 votos). Los accionistas también aprobaron una enmienda para suprimir el texto del Article EIGHTH, con 19,047,016 votos a favor.
Apyx Medical Corporation는 연례 주주총회에서 제출된 안건들의 결과를 발표했습니다. 주주들은 2026년 연례총회까지 임무를 수행할 이사 다섯 명을 선출했으며, 각 후보자는 찬성 18.88 million에서 19.11 million 사이의 표를 받았고 해당 집계에는 6.77 million의 브로커 무투표(broker non-votes)가 기록되었습니다. 주주들은 RSM US LLP를 회사의 독립 등록 회계법인으로 찬성 25,930,634표로 승인했습니다. 임원 보수에 관한 구속력 없는 권고 투표는 찬성 18,963,101표로 통과했습니다. 별도의 권고 투표에서 투표 빈도는 one-year 옵션(9,205,086표)을 선호했습니다. 또한 주주들은 Article EIGHTH의 문구를 삭제하는 수정안을 찬성 19,047,016표로 승인했습니다.
Apyx Medical Corporation a communiqué les résultats des résolutions soumises à son assemblée annuelle. Les actionnaires ont élu cinq administrateurs pour siéger au conseil jusqu'à l'assemblée de 2026 ; chaque candidat a obtenu entre 18.88 million et 19.11 million voix favorables, et 6.77 million de broker non-votes ont été enregistrés dans ces totaux. Les actionnaires ont ratifié RSM US LLP en tant que cabinet d'audit indépendant par 25,930,634 voix pour. Un vote consultatif non contraignant sur la rémunération des dirigeants a été approuvé par 18,963,101 voix pour. Un vote consultatif distinct sur la fréquence a favorisé l'option one-year (9,205,086 voix). Les actionnaires ont également approuvé un amendement visant à supprimer le texte de l'Article EIGHTH, avec 19,047,016 voix pour.
Apyx Medical Corporation gab die Ergebnisse der auf der Hauptversammlung vorgelegten Vorschläge bekannt. Die Aktionäre wählten fünf Direktoren in den Vorstand für die Amtszeit bis zur Hauptversammlung 2026; jeder Kandidat erhielt zwischen 18.88 million und 19.11 million Stimmen dafür, und in diesen Abstimmungen wurden 6.77 million Broker-Non-Votes verzeichnet. Die Anteilseigner ratifizierten RSM US LLP als unabhängige Wirtschaftsprüfungsgesellschaft mit 25,930,634 Stimmen für. Eine nicht bindende Beratungsabstimmung zur Vergütung der Führungskräfte wurde mit 18,963,101 Stimmen angenommen. Eine separate Beratungsabstimmung zur Häufigkeit bevorzugte die one-year-Option (9,205,086 Stimmen). Die Aktionäre stimmten außerdem einer Änderung zur Streichung des Wortlauts des Article EIGHTH mit 19,047,016 Stimmen zu.
- Five directors elected to serve through the 2026 annual meeting, each receiving strong affirmative vote totals
- RSM US LLP ratified as independent registered public accounting firm with 25,930,634 votes in favor
- Non-binding advisory vote on executive compensation approved with 18,963,101 votes for
- Charter amendment approved to delete the text of Article EIGHTH, receiving 19,047,016 votes in favor
- Significant broker non-votes of 6,772,342 were recorded in director and several proposal tallies
- Substantial abstentions on the frequency vote (2,489,782) may indicate shareholder uncertainty or withheld preferences
Insights
TL;DR: Board slate elected and charter amendment approved; advisory pay supported, frequency favored annually.
The meeting produced routine but material governance outcomes: the full board slate was elected with strong affirmative counts for each director, while a significant number of 6,772,342 broker non-votes appeared in director and certain proposal tallies, which is notable for vote context. The advisory "say-on-pay" received overwhelming support from voting shares cast (18,963,101 for), and shareholders selected a one-year frequency for future advisory votes. The charter amendment to delete Article EIGHTH was approved by a clear margin. These results reflect standard corporate governance actions rather than fundamental shifts in control or strategy.
TL;DR: Auditor ratified decisively; no auditor change risk indicated by vote totals.
The ratification of RSM US LLP as independent auditor passed overwhelmingly with 25,930,634 votes in favor and only 25,032 against, indicating broad shareholder acceptance of the firm. There were 67,823 abstentions recorded on that proposal. The strong margin reduces near-term audit continuity risk. Other proposals were governance-focused and do not disclose financial restatements or accounting changes. Overall, the votes present routine validation of existing audit and compensation arrangements.
Apyx Medical Corporation ha reso noti i risultati delle proposte sottoposte all'assemblea annuale. Gli azionisti hanno eletto cinque amministratori del consiglio per il mandato fino all'assemblea del 2026; ciascun candidato ha ottenuto tra 18.88 million e 19.11 million voti favorevoli, con 6.77 million di broker non-votes registrati in quei conteggi. I soci hanno ratificato RSM US LLP come società di revisione contabile indipendente con 25,930,634 voti a favore. Un voto consultivo non vincolante sulla retribuzione dei dirigenti è passato con 18,963,101 voti favorevoli. Una separata votazione consultiva sulla frequenza ha privilegiato l'opzione di one-year (9,205,086 voti). Gli azionisti hanno inoltre approvato una modifica per eliminare il testo dell'Article EIGHTH, con 19,047,016 voti a favore.
Apyx Medical Corporation informó los resultados de las propuestas sometidas a la junta anual. Los accionistas eligieron a cinco directores para que formen parte del consejo hasta la junta de 2026; cada nominado recibió entre 18.88 million y 19.11 million votos a favor, y se registraron 6.77 million de broker non-votes en esos recuentos. Los accionistas ratificaron a RSM US LLP como la firma independiente de auditoría con 25,930,634 votos a favor. Una votación consultiva no vinculante sobre la compensación ejecutiva fue aprobada con 18,963,101 votos a favor. Una votación consultiva separada sobre la frecuencia favoreció la opción de one-year (9,205,086 votos). Los accionistas también aprobaron una enmienda para suprimir el texto del Article EIGHTH, con 19,047,016 votos a favor.
Apyx Medical Corporation는 연례 주주총회에서 제출된 안건들의 결과를 발표했습니다. 주주들은 2026년 연례총회까지 임무를 수행할 이사 다섯 명을 선출했으며, 각 후보자는 찬성 18.88 million에서 19.11 million 사이의 표를 받았고 해당 집계에는 6.77 million의 브로커 무투표(broker non-votes)가 기록되었습니다. 주주들은 RSM US LLP를 회사의 독립 등록 회계법인으로 찬성 25,930,634표로 승인했습니다. 임원 보수에 관한 구속력 없는 권고 투표는 찬성 18,963,101표로 통과했습니다. 별도의 권고 투표에서 투표 빈도는 one-year 옵션(9,205,086표)을 선호했습니다. 또한 주주들은 Article EIGHTH의 문구를 삭제하는 수정안을 찬성 19,047,016표로 승인했습니다.
Apyx Medical Corporation a communiqué les résultats des résolutions soumises à son assemblée annuelle. Les actionnaires ont élu cinq administrateurs pour siéger au conseil jusqu'à l'assemblée de 2026 ; chaque candidat a obtenu entre 18.88 million et 19.11 million voix favorables, et 6.77 million de broker non-votes ont été enregistrés dans ces totaux. Les actionnaires ont ratifié RSM US LLP en tant que cabinet d'audit indépendant par 25,930,634 voix pour. Un vote consultatif non contraignant sur la rémunération des dirigeants a été approuvé par 18,963,101 voix pour. Un vote consultatif distinct sur la fréquence a favorisé l'option one-year (9,205,086 voix). Les actionnaires ont également approuvé un amendement visant à supprimer le texte de l'Article EIGHTH, avec 19,047,016 voix pour.
Apyx Medical Corporation gab die Ergebnisse der auf der Hauptversammlung vorgelegten Vorschläge bekannt. Die Aktionäre wählten fünf Direktoren in den Vorstand für die Amtszeit bis zur Hauptversammlung 2026; jeder Kandidat erhielt zwischen 18.88 million und 19.11 million Stimmen dafür, und in diesen Abstimmungen wurden 6.77 million Broker-Non-Votes verzeichnet. Die Anteilseigner ratifizierten RSM US LLP als unabhängige Wirtschaftsprüfungsgesellschaft mit 25,930,634 Stimmen für. Eine nicht bindende Beratungsabstimmung zur Vergütung der Führungskräfte wurde mit 18,963,101 Stimmen angenommen. Eine separate Beratungsabstimmung zur Häufigkeit bevorzugte die one-year-Option (9,205,086 Stimmen). Die Aktionäre stimmten außerdem einer Änderung zur Streichung des Wortlauts des Article EIGHTH mit 19,047,016 Stimmen zu.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934
Date of Report (date of earliest event reported)
(Exact name of registrant as specified in its charter)
(State or other jurisdiction of incorporation or organization) |
(Commission File Number) |
(I.R.S. Employer Identification No.) |
(Address of principal executive offices, zip code)
(Issuer’s telephone number)
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging
growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 5.07. Submission of Matters to a Vote of Security Holders.
On August 7, 2025, the following proposals were submitted to the stockholders of Apyx Medical Corporation (the “Company”) at its annual meeting of stockholders: (1) the election of five (5) directors; (2) the ratification of RSM US LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2025; (3) the approval of the a non-binding advisory resolution supporting the compensation of the Company’s named executive officers; (4) the approval of a non-binding advisory resolution supporting the frequency of an advisory vote on the compensation of the Company’s named executive officers; and (5) the approval of a resolution to amend the Company’s Certificate of Incorporation to remove Article EIGHTH and replace with “intentionally omitted.”
The proposals are described in more detail in the Company’s Definitive Proxy Statement on Schedule 14A filed with the U.S. Securities and Exchange Commission on June 25, 2025.
The following are the final voting results for each proposal:
Proposal 1: |
The Company’s stockholders elected each of the following five (5) directors to serve on the Board of Directors of the Company until the 2026 Annual Meeting of Stockholders or until their respective successors have been duly elected and qualified, by the following vote: |
| Name | Number of Votes Cast in Favor | Number of Votes Cast Against | Number of Votes Abstained | Broker Non-Votes | ||||
| Stavros G. Vizirgianakis | 19,107,606 | 105,624 | 37,917 | 6,772,342 | ||||
| Charles D. Goodwin | 18,943,570 | 249,305 | 58,272 | 6,772,342 | ||||
| Lawrence J. Waldman | 18,972,128 | 112,320 | 166,699 | 6,772,342 | ||||
| Minnie Baylor-Henry | 18,877,754 | 186,304 | 187,089 | 6,772,342 | ||||
| Wendy Levine | 18,931,749 | 132,382 | 187,016 | 6,772,342 |
Proposal 2: |
The Company’s stockholders ratified the appointment of RSM US LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2025, by the following vote: |
| Number of Votes Cast in Favor | Number of Votes Cast Against | Number of Votes Abstained | Broker Non-Votes | |||
| 25,930,634 | 25,032 | 67,823 | - |
Proposal 3: |
The Company’s stockholders approved of a non-binding advisory resolution supporting the compensation of the Company’s named executive officers, by the following vote: |
| Number of Votes Cast in Favor | Number of Votes Cast Against | Number of Votes Abstained | Broker Non-Votes | |||
| 18,963,101 | 182,700 | 105,346 | 6,772,342 |
| Proposal 4: | The Company’s stockholders approved the frequency of an advisory vote on the compensation of the named executive officers of the Company, by the following vote: |
| One Year | Two Years | Three Years | Number of Votes Abstained | Broker Non-Votes | ||||
| 9,205,086 | 25,369 | 7,530,910 | 2,489,782 | - |
|
Proposal 5: |
The Company’s stockholders approved the adoption of an amendment to the Company’s Certificate of Incorporation to delete the text of Article EIGHTH and replace with “intentionally omitted”, by the following vote: |
| Number of Votes Cast in Favor | Number of Votes Cast Against | Number of Votes Abstained | Broker Non-Votes | |||
| 19,047,016 | 99,065 | 105,066 | 6,772,342 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: August 13, 2025 |
Apyx Medical Corporation |
|
|
|
|
|
By: |
/s/ Matthew Hill |
|
|
Matthew Hill |
|
|
Chief Financial Officer, Secretary and Treasurer |
FAQ
What were the results of the APYX director elections?
Did APYX shareholders ratify the company’s auditor (APYX)?
How did APYX shareholders vote on executive compensation (say-on-pay)?
What frequency did APYX shareholders choose for future advisory votes on pay?
Was there any change to APYX’s Certificate of Incorporation?
